<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Fleroxacin_Guidance_As_Well_As_The_Urban_Myths</id>
		<title>Fleroxacin Guidance As Well As The Urban Myths - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Fleroxacin_Guidance_As_Well_As_The_Urban_Myths"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Fleroxacin_Guidance_As_Well_As_The_Urban_Myths&amp;action=history"/>
		<updated>2026-05-03T17:28:46Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Fleroxacin_Guidance_As_Well_As_The_Urban_Myths&amp;diff=186983&amp;oldid=prev</id>
		<title>Animal13neck: Створена сторінка: Current smoking is the main treatable contributor to hyperglycaemia. &quot;&quot;Emerging [https://en.wikipedia.org/wiki/Fleroxacin Fleroxacin] evidence indicates that pa...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Fleroxacin_Guidance_As_Well_As_The_Urban_Myths&amp;diff=186983&amp;oldid=prev"/>
				<updated>2017-06-09T02:23:03Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Current smoking is the main treatable contributor to hyperglycaemia. &amp;quot;&amp;quot;Emerging [https://en.wikipedia.org/wiki/Fleroxacin Fleroxacin] evidence indicates that pa...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Current smoking is the main treatable contributor to hyperglycaemia. &amp;quot;&amp;quot;Emerging [https://en.wikipedia.org/wiki/Fleroxacin Fleroxacin] evidence indicates that patients with chronic obstructive pulmonary disease (COPD) have a poorer vitamin D status than the general population, possibly affecting several comorbidities. In northern latitudes, these problems could be even more accentuated wintertime because of the low ultraviolet B radiation. To examine the dietary intake of vitamin D and the levels of 25-hydroxyvitamin D (25-OH-D) in a COPD population compared with a reference group in Swedish settings. Ninety-eight COPD patients (forced expiratory volume in?1?s/vital capacity ratio?[http://www.selleckchem.com/products/NVP-AUY922.html Luminespib clinical trial] Swedish population. Monitoring vitamin D status and possibly routinely treating COPD patients with vitamin D and calcium should be considered to minimise the risk of severe vitamin D deficiency among COPD patients. Chronic obstructive pulmonary disease (COPD) has several systemic symptoms and consequences [1, 2]. Malnutrition, muscle weakness and osteoporosis are common comorbidities [2-4] in COPD that can be linked to vitamin D deficiency. Treatment with calcium and vitamin D supplementation reduces [http://www.selleckchem.com/products/RO4929097.html www.selleckchem.com/products/RO4929097.html] not only the risk of osteoporotic fractures [5, 6], but interestingly also increases muscle strength and prevents falls [7]. This effect is mainly thought to be mediated by vitamin D. Vitamin D status is most commonly evaluated by measuring 25-hydroxyvitamin D (25-OH-D) instead of the active 1,25-dihydroxyvitamin D. The relative long half-life of 25-OH-D makes it a better marker for both dietary intake and skin synthesis from sun exposure [8]. The National Health and Nutrition Examination Survey (NHANES) III study showed a positive correlation between serum 25-OH-D levels and spirometry performance [9]. A subsequent study conducted in the UK on a small group of patients with COPD did not reach the same conclusion.&lt;/div&gt;</summary>
		<author><name>Animal13neck</name></author>	</entry>

	</feed>